- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Latest Conference Articles
The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.
Changing Paradigms-Integrating Novel Therapeutics Into the Standard of Care
April 18th 2011, 10:20am
Interdisciplinary Prostate Cancer Congress
Prostate cancer affects 1 of every 6 men in the United States
Considerations for Integrating Chemotherapy
April 18th 2011, 10:08am
Interdisciplinary Prostate Cancer Congress
Traditional, linear regimen of prostate cancer treatment may need to be reexamined as oncologists learn new ways to incorporate new therapies
Bone-Targeted Therapeutics
April 18th 2011, 10:03am
Interdisciplinary Prostate Cancer Congress
Initial clinical findings indicate that results with radiotherapies sometime improve when combined with immunotherapy
Immunotherapies: Avoiding collisions once the brake is released
April 13th 2011, 7:09am
Interdisciplinary Prostate Cancer Congress
Immunotherapies again made headlines in oncology last month
Novel Hormone-Radiation Therapy Approaches
April 12th 2011, 6:07am
Interdisciplinary Prostate Cancer Congress
Radiation therapy (RT) used in combination with hormonal approaches continues to be a viable strategy for treating localized high-risk prostate cancer patients
PSA: To Screen or Not to Screen
April 12th 2011, 5:56am
Interdisciplinary Prostate Cancer Congress
Screening for prostate cancer does work, despite controversy about its efficacy, according to IPCC Co-chair Leonard G. Gomella
Integrating New Hormonal Therapies in Advanced Disease
April 11th 2011, 12:12pm
Interdisciplinary Prostate Cancer Congress
Hormonal therapies have long been the standard of care for metastatic advanced prostate cancer
Novel vaccine approaches: Prospects for PROSTVAC®-VF are bright
April 11th 2011, 12:03pm
Interdisciplinary Prostate Cancer Congress
As research into novel vaccine approaches for treating advanced prostate cancer continues...
The Overtreatment of Prostate Cancer
April 11th 2011, 11:59am
Interdisciplinary Prostate Cancer Congress
Increased prostate cancer screening has led to overtreatment and has not significantly reduced mortality rates in prostate cancer
Breast Reconstruction Trainee Assessment
March 18th 2011, 2:04pm
PER® Miami Breast Cancer Conference
In this podcast, Maisam Fazel, FRCS, MS, MB BChir, discusses his research into a checklist for breast cancer surgeons.
Dr. Osman on Designing the Program for the MBCC
March 16th 2011, 12:25pm
PER® Miami Breast Cancer Conference
Dr. Daniel Osman, director of the Miami Breast Cancer Conference, on Designing the Program for the MBCC
Dr. Fazel on Trends in Surgical Training
March 14th 2011, 1:56pm
PER® Miami Breast Cancer Conference
Maisam Fazel, FRCS, MS, MB BChir, of Imperial College Healthcare NHS Trust in the United Kingdom on Trends in Surgical Training
Need for Survivorship Plans Emphasized
March 14th 2011, 5:08am
PER® Miami Breast Cancer Conference
As the number of breast cancer survivors grows, so does the emphasis on establishing individualized survivorship plans
Preoperative Therapy Offers Value to Patients
March 14th 2011, 5:07am
PER® Miami Breast Cancer Conference
Preoperative neoadjuvant systemic therapy can be valuable for patients even if they do not achieve a pathologic complete response
Framework for Evaluating Trial Results Detailed
March 14th 2011, 5:04am
PER® Miami Breast Cancer Conference
With thousands of clinical trials in play, many oncology specialists are reluctant to embrace findings from newly-released studies
Genomic Profiles as Routine Care Are a Hot Topic
March 14th 2011, 5:02am
PER® Miami Breast Cancer Conference
Should genomic profiles be used routinely to determine which breast cancer patients receive adjuvant chemotherapy
Personalized Treatment With Adjuvant Chemotherapy Shows Marginal Progress
March 14th 2011, 5:00am
PER® Miami Breast Cancer Conference
Personalized treatment in oncology is a popular concept these days, but the goal remains elusive
A Call for Change in Treating DCIS
March 11th 2011, 10:00am
PER® Miami Breast Cancer Conference
It is time to rethink the way oncologists in the United States are treating ductal carcinoma in situ